- Home
- DHI vs HLN Comparison
DHI vs HLN Comparison
Compare DHI & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHI
- HLN
- Stock Information
- Founded
- DHI 1978
- HLN 2022
- Country
- DHI United States
- HLN United Kingdom
- Employees
- DHI N/A
- HLN N/A
- Industry
- DHI Homebuilding
- HLN Package Goods/Cosmetics
- Sector
- DHI Consumer Discretionary
- HLN Consumer Discretionary
- Exchange
- DHI Nasdaq
- HLN Nasdaq
- Market Cap
- DHI 51.3B
- HLN 48.2B
- IPO Year
- DHI 1992
- HLN N/A
- Fundamental
- Price
- DHI $169.92
- HLN $9.39
- Analyst Decision
- DHI Buy
- HLN Buy
- Analyst Count
- DHI 15
- HLN 2
- Target Price
- DHI $165.57
- HLN $10.95
- AVG Volume (30 Days)
- DHI 3.5M
- HLN 8.5M
- Earning Date
- DHI 10-28-2025
- HLN 07-31-2025
- Dividend Yield
- DHI 0.94%
- HLN 1.92%
- EPS Growth
- DHI N/A
- HLN 41.64
- EPS
- DHI 12.48
- HLN 0.23
- Revenue
- DHI $34,575,200,000.00
- HLN $15,096,588,575.00
- Revenue This Year
- DHI N/A
- HLN $1.13
- Revenue Next Year
- DHI $2.02
- HLN $4.23
- P/E Ratio
- DHI $13.62
- HLN $41.08
- Revenue Growth
- DHI N/A
- HLN N/A
- 52 Week Low
- DHI $110.44
- HLN $8.86
- 52 Week High
- DHI $199.85
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- DHI 51.62
- HLN 37.71
- Support Level
- DHI $168.02
- HLN $9.26
- Resistance Level
- DHI $181.47
- HLN $9.92
- Average True Range (ATR)
- DHI 4.73
- HLN 0.13
- MACD
- DHI -1.58
- HLN -0.04
- Stochastic Oscillator
- DHI 20.19
- HLN 17.99
About DHI D.R. Horton Inc.
With operations in 126 markets across 36 states D.R. Horton is the leading homebuilder in the United States. D.R. Horton mainly builds single-family detached homes (87% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. D.R. Horton's headquarters are in Arlington, Texas, and it manages six regional segments across the United States.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.